BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34958107)

  • 1. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).
    Votavova H; Belickova M
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
    Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoplastic form of myelodysplastic neoplasm.
    Votavová H; Lenertová Z; Votava T; Beličková M
    Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological derangement in hypocellular myelodysplastic syndromes.
    Serio B; Risitano A; Giudice V; Montuori N; Selleri C
    Transl Med UniSa; 2014 Jan; 8():31-42. PubMed ID: 24778996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    Barrett J; Saunthararajah Y; Molldrem J
    Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
    Fattizzo B; Serpenti F; Barcellini W; Caprioli C
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401595
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of clonal hematopoiesis and disease boundaries in bone marrow failure diseases].
    Suzuki T
    Rinsho Ketsueki; 2023; 64(6):474-481. PubMed ID: 37407470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
    Karantanos T; DeZern AE
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDS overlap disorders and diagnostic boundaries.
    Tanaka TN; Bejar R
    Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
    Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
    Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
    Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
    Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
    Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
    Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aplastic anemia: Pathophysiology.
    Giudice V; Selleri C
    Semin Hematol; 2022 Jan; 59(1):13-20. PubMed ID: 35491054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation.
    Durrani J; Groarke EM
    Semin Hematol; 2022 Jul; 59(3):137-142. PubMed ID: 36115690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.
    Barcellini W
    Expert Rev Hematol; 2017 Jul; 10(7):649-657. PubMed ID: 28586251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing in hypoplastic bone marrow failure: What difference does it make?
    Skibenes ST; Clausen I; Raaschou-Jensen K
    Eur J Haematol; 2021 Jan; 106(1):3-13. PubMed ID: 32888355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia.
    Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M
    Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.
    Zhao XC; Ju B; Xiu NN; Sun XY; Meng FJ
    Front Immunol; 2024; 15():1339971. PubMed ID: 38426096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.